News
Governor Hochul Announces New Members of New York’s Emerging Technology Advisory Board Focused on Biotechnology
Overview
Governor Kathy Hochul announced the creation of New York’s Emerging Technology Advisory Board on Biotechnology, a group of industry, research, and nonprofit leaders tasked with guiding the state’s biotech growth. The board will focus on advancing commercialization of new therapies, fostering public–private partnerships, integrating AI in biotech, and expanding workforce development. This marks the second phase of the Advisory Board, which last year focused on Artificial Intelligence and informed new state AI programs.
The Big Picture
The initiative builds on Hochul’s broader strategy to make New York a leader in emerging technologies, backed by more than $354 million in life sciences investments and major projects like Roswell Park’s cell therapy hub and the $430 million New York Biogenesis Park. Overall, the board is part of a push to position New York as a national hub for biotechnology, innovation, and high-skilled job creation.
